Biohaven Number of Employees 2016-2022 | BHVN

Biohaven number of employees from 2016 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Biohaven Annual Number of Employees
2021 928
2020 825
2019 647
2018 63
2017 42
2016 12
2015
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.127B $0.463B
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $171.964B 10.49
GSK (GSK) United Kingdom $71.240B 8.93
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.458B 19.56
Ginkgo Bioworks Holdings (DNA) United States $3.841B 0.00
Myovant Sciences (MYOV) United Kingdom $2.593B 0.00
Arcus Biosciences (RCUS) United States $2.495B 37.46
Emergent Biosolutions (EBS) United States $0.589B 4.63
Zymeworks (ZYME) Canada $0.487B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.267B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
SQZ Biotechnologies (SQZ) United States $0.052B 0.00
Gelesis Holdings (GLS) United States $0.025B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00